Plain-English translation of NCT07713537 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This research study is trying to create a better tool to predict which patients with atrial fibrillation (an irregular heartbeat) might have a stroke, even while taking direct oral anticoagulants (blood thinners). Doctors know that some patients still experience strokes despite this medication, but they don't have a reliable way to identify who is at highest risk. This study will look at medical information from patients like you to build a better prediction tool.
Even with modern blood-thinning medications, some patients with irregular heartbeat still have strokes. Doctors need a better way to identify which patients are at greatest risk so they can provide more personalized care and potentially prevent these serious events.
You likely qualify if…
You likely don't qualify if…
You would be part of one of two groups: either patients currently taking blood thinners for irregular heartbeat, or patients who have had a stroke despite taking this medication. The study involves sharing your medical information and records with the research team so they can identify patterns that predict stroke risk. You'll need to remain in the study for at least 3 months and may have follow-up visits or phone calls to check on your health status.
AI-generated summary from trial data · Aug 6, 2026 · Not medical advice
Spain
Sponsor
Hospital Universitari Vall d'Hebron Research Institute
Enrollment target
~250 participants
Started
January 2025
Primary completion
December 2027
Last updated on clinicaltrials.gov in July 2026.
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.